MBX Biosciences
MBX Biosciences is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
About MBX Biosciences
MBX Biosciences is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
MBX Biosciences is a clinical-stage biotechnology company developing precision peptide therapeutics to treat endocrine and metabolic diseases using a proprietary peptide discovery and development platform (PEPs). The company maintains a pipeline of peptide candidates in various stages of clinical development focused on improving management of endocrine and metabolic disorders.
Explore MBX Biosciences's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.